Vanguard Group’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Vanguard Group’s Portfolio AUXL Stock Details AUXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-3,098,033	Closed	-$107M	–	4202
2014 Q4	$107M	Buy	3,098,033 +82,543	+3%	+$2.69M	0.01%	1375
2014 Q3	$90M	Sell	3,015,490 -6,811	-0.2%	-$144K	0.01%	1428
2014 Q2	$60.6M	Buy	3,022,301 +4,914	+0.2%	+$113K	﹤0.01%	1732
2014 Q1	$82M	Sell	3,017,387 -113,663	-4%	-$3.02M	0.01%	1482
2013 Q4	$64.9M	Buy	3,131,050 +126,078	+4%	+$2.38M	0.01%	1618
2013 Q3	$54.8M	Buy	3,004,972 +50,624	+2%	+$915K	0.01%	1667
2013 Q2	$49.1M	Buy	+2,954,348	New	+$47.2M	0.01%	1651

Other funds holding AUXL

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Vanguard Group's AUXL Position: Q1 2015 in Review

Vanguard Group sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 3,098,033 shares — an estimated $107M sold.

Vanguard Group first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $107M in Q4 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

Vanguard Group reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Vanguard Group sold 3,098,033 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $107M.
Vanguard Group first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
Vanguard Group's AUXILIUM PHARAMCEUTICALS INC position peaked at $107M in Q4 2014.
1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on Vanguard Group's 13F filing for Q1 2015, filed 14 May 2015.